Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus
about
Dengue virus pathogenesis: an integrated viewExploring the full spectrum of macrophage activationRole of dendritic cells in antibody-dependent enhancement of dengue virus infectionMultiple immune factors are involved in controlling acute and chronic chikungunya virus infectionThe role of macrophages and dendritic cells in the initiation of inflammation in IBDInhibition of Transcription and Translation in Sindbis Virus-Infected CellsDifferential Induction of Type I Interferon Responses in Myeloid Dendritic Cells by Mosquito and Mammalian-Cell-Derived AlphavirusesComplement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific MannerDifference between the Abilities of Human Fc Receptor-Expressing CV-1 Cells To Neutralize American and Asian Genotypes of Dengue Virus 2Evasion of innate and adaptive immunity by flavivirusesChikungunya virus arthritis in adult wild-type mice.Porcine FcγRIIb mediates enhancement of porcine reproductive and respiratory syndrome virus (PRRSV) infection.Enterovirus 71 infection of monocytes with antibody-dependent enhancementCytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexesMacrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus.Identification and characterization of a ross river virus variant that grows persistently in macrophages, shows altered disease kinetics in a mouse model, and exhibits resistance to type I interferonPatterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection.Pathogenesis of aleutian mink disease parvovirus and similarities to b19 infection.Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy.Macrophages and control of granulomatous inflammation in tuberculosis.Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans.Fc receptors in antibody-dependent enhancement of viral infections.IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba.Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.An in vitro model for dengue virus infection that exhibits human monocyte infection, multiple cytokine production and dexamethasone immunomodulation.Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity.
P2860
Q24645380-9AA2CB40-E1AF-41B6-BC9F-3E41EA74F6F1Q24653754-B8953FF1-007B-4F2E-868F-9171218B8A03Q24655655-D549A667-68D2-4918-A15C-16244E828C9BQ24701792-694982FC-23D0-46A7-AFC6-A4134B8BBB29Q26827408-89B7B295-AEF9-4E29-B3B4-A76C740C8D16Q27470247-D157738E-2E02-4FBF-AD0E-910914FEA001Q27478027-66A824C0-7F94-4C9A-9CF3-C00D387CCEA9Q27485131-7FC0A3E1-EBBB-45A7-BB31-33C918CDC864Q27487941-9FDB0A86-49C1-4133-9887-1509313447A2Q28204656-D6371F85-67AD-4F29-9341-C73E0897A653Q34046030-A49E6F84-08AF-49F0-B8AF-1D49DA720659Q34119043-54668018-CB67-4CDC-9512-ED2740AEBDC3Q34189997-0951AB73-251E-4FD7-A326-FB900BB6EDDFQ34353365-0E69F7BB-5D4E-472F-A88C-860A106325AAQ34671059-CDE4995B-57EB-4154-BDD4-C36A0664F5DAQ34773767-21D0D209-D263-4E4D-9BD9-54A4A6D56C4FQ34982662-47CC1381-52B4-4124-84A1-9541FF0EDC8AQ35097474-7C33A565-A936-4591-9078-C10A776F30CEQ36326294-71104883-16D0-4169-8932-DB886D2574C2Q36628520-28E065E4-D57A-44E2-8CFE-C326FF5E3CCDQ37856707-29BF3613-78F2-4379-B851-6188DD74E7A4Q38045381-1D273CA2-D508-405E-B9D4-93E5AA8BF432Q38615396-979593DB-D0BC-427D-AAC6-CF65E00D7446Q39372304-AAA6A27A-960B-483B-9008-D9E4F0B2BEE3Q40341836-B9F0938B-03EF-4AAF-BD81-DCC1218296FAQ40429067-EEF68C07-0EC0-4216-A266-1767C5114785Q45740034-D9BF0043-499B-4F79-A121-2ADB0A5BBD36Q47547788-C810D798-F789-45E7-9E79-FF508327DC86
P2860
Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Suppression of lipopolysacchar ...... infection by Ross River virus
@ast
Suppression of lipopolysacchar ...... infection by Ross River virus
@en
Suppression of lipopolysacchar ...... infection by Ross River virus
@nl
type
label
Suppression of lipopolysacchar ...... infection by Ross River virus
@ast
Suppression of lipopolysacchar ...... infection by Ross River virus
@en
Suppression of lipopolysacchar ...... infection by Ross River virus
@nl
prefLabel
Suppression of lipopolysacchar ...... infection by Ross River virus
@ast
Suppression of lipopolysacchar ...... infection by Ross River virus
@en
Suppression of lipopolysacchar ...... infection by Ross River virus
@nl
P2860
P921
P356
P1476
Suppression of lipopolysacchar ...... infection by Ross River virus
@en
P2093
Brett A Lidbury
Surendran Mahalingam
P2860
P304
13819-13824
P356
10.1073/PNAS.202415999
P407
P577
2002-10-03T00:00:00Z